Literature DB >> 15707463

Risk factors of mortality for nosocomial pneumonia: importance of initial anti-microbial therapy.

S-C Lee1, C-C Hua, T-J Yu, W B Shieh, L-C See.   

Abstract

Nosocomial pneumonia is a common nosocomial infection and has high mortality rate. Risk factors of mortality of nosocomial pneumonia were studied in 132 hospitalised patients who developed nosocomial pneumonia. The overall mortality rate was 64/132, 48.5%. Of the 11 risk factors univariately associated with mortality due to nosocomial pneumonia, only the inappropriate initial anti-microbial therapy, high simplified acute physiology score and multiple organ failures remained significant after stepwise logistic regression. Gram-negative bacilli were still the most pre-dominant causative microbiologic agents of nosocomial pneumonia with Pseudomonas aeruginosa (20.3%), Acinetobacter baumannii (18.6%) and Escherichia coli (5.9%) being the three most predominant pathogens. A. baumannii were significantly more predominant among non-survivors than survivors (13.56 vs. 5.08%, p=0.0418). The incidence rate of methicillin-resistant Staphylococcus aureus was 19.5% higher than previous reports. We conclude that inappropriate initial anti-microbial therapy for nosocomial pneumonia is associated with the mortality rate of nosocomial pneumonia, and appropriate anti-microbial therapy improves outcome of nosocomial pneumonia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15707463     DOI: 10.1111/j.1742-1241.2005.00281.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  10 in total

1.  Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia.

Authors:  Regina B Osih; Jessina C McGregor; Shayna E Rich; Anita C Moore; Jon P Furuno; Eli N Perencevich; Anthony D Harris
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

2.  Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages.

Authors:  Kari R Wilson; Jennifer M Napper; James Denvir; Vincent E Sollars; Hongwei D Yu
Journal:  Microbiology       Date:  2007-04       Impact factor: 2.777

3.  C. elegans SWAN-1 Binds to EGL-9 and regulates HIF-1-mediated resistance to the bacterial pathogen Pseudomonas aeruginosa PAO1.

Authors:  Zhiyong Shao; Yi Zhang; Qi Ye; Jenifer Neeta Saldanha; Jo Anne Powell-Coffman
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

4.  Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.

Authors:  Rebecca H Sunenshine; Marc-Oliver Wright; Lisa L Maragakis; Anthony D Harris; Xiaoyan Song; Joan Hebden; Sara E Cosgrove; Ashley Anderson; Jennifer Carnell; Daniel B Jernigan; David G Kleinbaum; Trish M Perl; Harold C Standiford; Arjun Srinivasan
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

5.  Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia.

Authors:  Juthamas Inchai; Chaicharn Pothirat; Chaiwat Bumroongkit; Atikun Limsukon; Weerayut Khositsakulchai; Chalerm Liwsrisakun
Journal:  J Intensive Care       Date:  2015-03-02

6.  Factors Associated with Mortality in Immunocompetent Patients with Hospital-acquired Pneumonia.

Authors:  Pavaruch Sangmuang; Aroonrut Lucksiri; Wasan Katip
Journal:  J Glob Infect Dis       Date:  2019 Jan-Mar

Review 7.  Lung and gut microbiomes in pulmonary aspergillosis: Exploring adjunctive therapies to combat the disease.

Authors:  Liuyang Cai; Peigen Gao; Zeyu Wang; Chenyang Dai; Ye Ning; Macit Ilkit; Xiaochun Xue; Jinzhou Xiao; Chang Chen
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

Review 8.  Prevalence and Predictive Factors for Nosocomial Infection in the Military Hospitals: A Systematic Review and Meta-Analysis.

Authors:  Ehsan Teymourzadeh; Mohamadkarim Bahadori; Hamed Fattahi; Hossein Ali Rahdar; Sima Mirzaei Moghadam; Azad Shokri
Journal:  Iran J Public Health       Date:  2021-01       Impact factor: 1.429

9.  Attributable mortality of Acinetobacter baumannii: no longer a controversial issue.

Authors:  Matthew E Falagas; Petros I Rafailidis
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

10.  Implementation of a computerized decision support system to improve the appropriateness of antibiotic therapy using local microbiologic data.

Authors:  Manuel Rodriguez-Maresca; Antonio Sorlozano; Magnolia Grau; Rocio Rodriguez-Castaño; Andres Ruiz-Valverde; Jose Gutierrez-Fernandez
Journal:  Biomed Res Int       Date:  2014-08-17       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.